Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960 -: Efficiency of the DTwP vaccine-induced immunity against currently circulating B-pertussis isolates

被引:41
作者
Gzyl, A
Augustynowicz, E
Gniadek, G
Rabczenko, D
Dulny, G
Slusarczyk, J
机构
[1] Natl Inst Hyg, Dept Sera & Vaccines Evaluat, PL-00791 Warsaw, Poland
[2] Natl Inst Hyg, Dept Med Stat, PL-00791 Warsaw, Poland
[3] Prov Publ Hlth Lab, Dept Epidemiol, Warsaw, Poland
关键词
Bordetella pertussis; DTP vaccine; intranasal model;
D O I
10.1016/j.vaccine.2003.12.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study indicates that the appearance of the B. pertussis harbouring prn2 gene allele variant (not found among clinical isolates before 1990s) may have been induced by long-term vaccination in Poland with DTP-composed vaccine strains presenting exclusively prn1. However, ptxS1A allele of pertussis toxin subunit S1 encoding gene, predominant in the currently isolated B. pertussis strains, has been found in vaccine strains used for whole-cell pertussis component (wP) production of DTP vaccine in 1960-1978. This outrules the possibility that the appearance of ptxS1A allele might be related to vaccine pressure driven by non-ptxS1A vaccine strains used for long-term immunization with wP. Intranasal challenge animal model testing the efficiency of the clearance of B. pertussis strains harbouring different ptxS1lprn allele gene combinations revealed that currently produced DTwP vaccine may not contain adequate B. pertussis vaccine strains, since isolates with gene variants different from those observed in vaccine strains were eliminated from the lungs of the immunized animals with lower efficiency. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2122 / 2128
页数:7
相关论文
共 25 条
[1]   Intranasal murine model of Bordetella pertussis infection:: II.: Sequence variation and protection induced by a tricomponent acellular vaccine [J].
Boursaux-Eude, C ;
Thiberge, S ;
Carletti, G ;
Guiso, N .
VACCINE, 1999, 17 (20-21) :2651-2660
[2]   Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999 [J].
Cassiday, P ;
Sanden, G ;
Heuvelman, K ;
Mooi, F ;
Bisgard, KM ;
Popovic, T .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1402-1408
[3]   Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom [J].
Fry, NK ;
Neal, S ;
Harrison, TG ;
Miller, E ;
Matthews, R ;
George, RC .
INFECTION AND IMMUNITY, 2001, 69 (09) :5520-5528
[4]   Impact of anti-vaccine movements on pertussis control: the untold story [J].
Gangarosa, EJ ;
Galazka, AM ;
Wolfe, CR ;
Phillips, LM ;
Gangarosa, RE ;
Miller, E ;
Chen, RT .
LANCET, 1998, 351 (9099) :356-361
[5]   Intranasal murine model of Bordetella pertussis infection.: I.: Prediction of protection in human infants by acellular vaccines [J].
Guiso, N ;
Capiau, C ;
Carletti, G ;
Poolman, J ;
Hauser, P .
VACCINE, 1999, 17 (19) :2366-2376
[6]   Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines [J].
Guiso, N ;
Boursaux-Eude, C ;
Weber, C ;
Hausman, SZ ;
Sato, H ;
Iwaki, M ;
Kamachi, K ;
Konda, T ;
Burns, DL .
VACCINE, 2001, 19 (23-24) :3248-3252
[7]   Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland [J].
Gzyl, A ;
Augustynowicz, E ;
van Loo, I ;
Slusarczyk, J .
VACCINE, 2001, 20 (3-4) :299-303
[8]  
GZYL A, 2004, IN PRESS INT J EPIDE, V33
[9]  
Hardwick TH, 2002, EMERG INFECT DIS, V8, P44
[10]   Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity [J].
King, AJ ;
Berbers, G ;
van Oirschot, HFLM ;
Hoogerhout, P ;
Knipping, K ;
Mooi, FR .
MICROBIOLOGY-SGM, 2001, 147 :2885-2895